RxDoctor Payments Data

Suzanne Tingley, MD

Family Medicine · Old Saybrook, CTNPI 1063834448

Payments from drug & device makers

$391in general payments, 2019–2025

Across 21 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$74
  • Astellas Pharma US Inc$66
  • GSK$65
  • Novo Nordisk$44
  • Pfizer$39
  • Boehringer Ingelheim$36
  • plus $67 from 3 others

What the payments were for

  • Food & beverage$391100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$391 in reported general payments places this provider in the 55th percentile of 588 family medicine providers in Connecticut.

See all family medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$110,247
Medicare patients
219
Services billed
1,094

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide125$119,589
EliquisApixaban71$66,899
JardianceEmpagliflozin31$49,047
JanuviaSitagliptin Phosphate27$29,631
XareltoRivaroxaban24$25,783
ProliaDenosumab13$23,087
MyrbetriqMirabegron16$17,164
TrulicityDulaglutide16$15,384
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr25$15,167
SymbicortBudesonide/Formoterol Fumarate32$9,112
SynthroidLevothyroxine Sodium111$7,661
Breo ElliptaFluticasone/Vilanterol12$6,067
Qvar RedihalerBeclomethasone Dipropionate15$5,628
Bromocriptine Mesylate13$5,497
SavaysaEdoxaban Tosylate13$5,448

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$44$119,589125 claims
PfizerEliquis$39$66,89971 claims
Boehringer IngelheimJardiance$36$49,04731 claims
GSKAnoro Ellipta, Breo Ellipta$65$21,23537 claims
Astellas Pharma US IncMyrbetriq$66$17,16416 claims
Lilly USA, LLCTrulicity$74$15,38416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 588 family medicine providers in Connecticut.

Other family medicine in Old Saybrook

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →